Morningstar® Stock Report™

Regeneron Pharmaceuticals Inc REGN

Margenes (% sobre Ventas)
20192020202120222023
Ingresos100.00%100.00%100.00%100.00%100.00%
Coste de Ventas9.95%13.18%15.17%12.82%13.84%
Margen Bruto90.05%86.82%84.83%87.18%86.16%
Ventas, general y administración23.33%15.84%11.35%17.38%20.06%
Investigación y Desarrollo38.62%32.19%18.09%29.51%33.84%
Margen Operativo28.10%42.09%55.67%41.03%32.27%
Net Int, Inc and Other58.99%86.94%113.69%80.94%64.29%
Margen sobre Beneficio antes de impuestos30.89%44.84%58.03%39.91%32.01%
Rendimiento
20192020202120222023
Tipo impositivo3.98%3.50%7.78%4.28%1.87%
Margen Neto26.91%41.35%50.25%35.64%30.14%
Rendimiento sobre Activos (ROA)15.9421.9837.9115.8812.69
Financial Leverage1.341.561.361.291.27
Rendimiento sobre Fondos Propios (ROE)21.3231.7754.2120.9416.26
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures